INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
64 hedge funds and large institutions have $53.5M invested in Infinity Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
Holders
64
Holding in Top 10
–
Calls
$654K
Puts
$135K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$955K | |
| 3 | +$787K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$378K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$371K |
Top Sellers
| 1 | -$7.54M | |
| 2 | -$3.67M | |
| 3 | -$791K | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$747K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$585K |